173 related articles for article (PubMed ID: 23066031)
1. Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance.
Broustas CG; Zhu A; Lieberman HB
J Biol Chem; 2012 Nov; 287(49):41324-33. PubMed ID: 23066031
[TBL] [Abstract][Full Text] [Related]
2. RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.
Broustas CG; Lieberman HB
Prostate; 2014 Oct; 74(14):1359-70. PubMed ID: 25111005
[TBL] [Abstract][Full Text] [Related]
3. FOXP1 and NDRG1 act differentially as downstream effectors of RAD9-mediated prostate cancer cell functions.
Panigrahi SK; Broustas CG; Cuiper PQ; Virk RK; Lieberman HB
Cell Signal; 2021 Oct; 86():110091. PubMed ID: 34298089
[TBL] [Abstract][Full Text] [Related]
4. Regulation of NEIL1 protein abundance by RAD9 is important for efficient base excision repair.
Panigrahi SK; Hopkins KM; Lieberman HB
Nucleic Acids Res; 2015 May; 43(9):4531-46. PubMed ID: 25873625
[TBL] [Abstract][Full Text] [Related]
5. Rad9 has a functional role in human prostate carcinogenesis.
Zhu A; Zhang CX; Lieberman HB
Cancer Res; 2008 Mar; 68(5):1267-74. PubMed ID: 18316588
[TBL] [Abstract][Full Text] [Related]
6. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance.
Sakamoto S; McCann RO; Dhir R; Kyprianou N
Cancer Res; 2010 Mar; 70(5):1885-95. PubMed ID: 20160039
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer.
Virtakoivu R; Pellinen T; Rantala JK; Perälä M; Ivaska J
Mol Biol Cell; 2012 Sep; 23(17):3357-69. PubMed ID: 22809628
[TBL] [Abstract][Full Text] [Related]
8. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
9. DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.
Zhu A; Hopkins KM; Friedman RA; Bernstock JD; Broustas CG; Lieberman HB
Carcinogenesis; 2021 Feb; 42(2):220-231. PubMed ID: 32780107
[TBL] [Abstract][Full Text] [Related]
10. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
11. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
[TBL] [Abstract][Full Text] [Related]
12. Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.
Jin JK; Tien PC; Cheng CJ; Song JH; Huang C; Lin SH; Gallick GE
Oncogene; 2015 Apr; 34(14):1811-21. PubMed ID: 24793790
[TBL] [Abstract][Full Text] [Related]
13. Contributions of Rad9 to tumorigenesis.
Broustas CG; Lieberman HB
J Cell Biochem; 2012 Mar; 113(3):742-51. PubMed ID: 22034047
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management.
Lieberman HB; Rai AJ; Friedman RA; Hopkins KM; Broustas CG
Transl Cancer Res; 2018 Jul; 7(Suppl 6):S651-S661. PubMed ID: 30079300
[TBL] [Abstract][Full Text] [Related]
15. Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.
Hu S; Delorme N; Liu Z; Liu T; Velasco-Gonzalez C; Garai J; Pullikuth A; Koochekpour S
Mol Cancer; 2010 Feb; 9():30. PubMed ID: 20132547
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
17. Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.
Hensley PJ; Desiniotis A; Wang C; Stromberg A; Chen CS; Kyprianou N
PLoS One; 2014; 9(1):e86238. PubMed ID: 24497940
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
19. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
20. Regulation of inside-out β1-integrin activation by CDCP1.
Pollan SG; Huang F; Sperger JM; Lang JM; Morrissey C; Cress AE; Chu CY; Bhowmick NA; You S; Freeman MR; Spassov DS; Moasser MM; Carter WG; Satapathy SR; Shah K; Knudsen BS
Oncogene; 2018 May; 37(21):2817-2836. PubMed ID: 29511352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
